Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Shigenori Hiruma"'
Autor:
Hideyuki Imai, Natsuko Watanabe, Rei Hirose, Masakazu Koshibu, Masahiro Ichikawa, Akiko Sankoda, Shigenori Hiruma, Nami Suzuki, Masako Matsumoto, Miho Fukushita, Ai Yoshihara, Jaeduk Yoshimura Noh, Kiminori Sugino, Koichi Ito
Publikováno v:
European Thyroid Journal, Vol 13, Iss 5, Pp 1-8 (2024)
Objective: There are few reports of subacute thyroiditis (SAT) during pregnancy. This study aimed to clarify the clinical characteristics of SAT in pregnant patients. Methods and results: Seven patients diagnosed with SAT during pregnancy at our inst
Externí odkaz:
https://doaj.org/article/8d70dc4737c84cec8431b5496bd93571
Autor:
Jaeduk Yoshimura Noh, Kosuke Inoue, Nami Suzuki, Ai Yoshihara, Miho Fukushita, Masako Matsumoto, Hideyuki Imai, Shigenori Hiruma, Masahiro Ichikawa, Masakazu Koshibu, Akiko Sankoda, Rei Hirose, Natsuko Watanabe, Kiminori Sugino, Koichi Ito
Publikováno v:
Endocrine Journal, Vol 71, Iss 7, Pp 695-703 (2024)
Agranulocytosis is a serious adverse effect of methimazole (MMI) and propylthiouracil (PTU), and although there have been reports suggesting a dose-dependent incidence in relation to both drugs, the evidence has not been conclusive. The objective of
Externí odkaz:
https://doaj.org/article/2c9df66a660949b9b940fac9ff8396e4
Autor:
Natsuko Watanabe, Jaeduk Yoshimura Noh, Ai Kozaki, Ran Yoshimura, Ai Yoshihara, Nami Suzuki, Masako Matsumoto, Miho Fukushita, Aya Kinoshita, Azusa Aida, Hideyuki Imai, Shigenori Hiruma, Toshu Inoue, Kosuke Inoue, Kiminori Sugino, Koichi Ito
Publikováno v:
Endocrine Journal, Vol 70, Iss 11, Pp 1087-1096 (2023)
Appropriate administration of anti-inflammatory and immunosuppressive treatment (AIIST) is important for patients with Graves’ orbitopathy (GO). This study aimed to clarify the incidence and risk factors for GO treated with AIIST and propose a pred
Externí odkaz:
https://doaj.org/article/90d4d07978994afd933f8b45f5c2c7a1
Autor:
Shigenori Hiruma, Fumika Shigiyama, Shinji Hisatake, Sunao Mizumura, Nobuyuki Shiraga, Masaaki Hori, Takanori Ikeda, Takahisa Hirose, Naoki Kumashiro
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background While the cardioprotective benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors have been established in patients with cardiovascular disease (CVD), their advantages over other anti-diabetic drugs at earlier stages remain
Externí odkaz:
https://doaj.org/article/34b99b5f900c4db7aaf8536df3e9e7f9
Autor:
Jaeduk Yoshimura Noh, Ai Yoshihara, Shigenori Hiruma, Masahiro Ichikawa, Rei Hirose, Masakazu Koshibu, Hideyuki Imai, Akiko Sankoda, Nami Suzuki, Miho Fukushita, Masako Matsumoto, Natsuko Watanabe, Kiminori Sugino, Koichi Ito
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 16, p2259-2268, 10p
Autor:
Ai Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, Natsuko Watanabe, Miho Fukushita, Masako Matsumoto, Nami Suzuki, Ai Suzuki, Aya Kinoshita, Ran Yoshimura, Azusa Aida, Hideyuki Imai, Shigenori Hiruma, Kiminori Sugino, Koichi Ito
Publikováno v:
Thyroid. 33:373-379
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f24c718660e2ca5e13b2183743a7cc4d
https://doi.org/10.1089/thy.2022.0514
https://doi.org/10.1089/thy.2022.0514
Publikováno v:
Diabetes, Obesity and Metabolism. 25:1576-1588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::839f383efccdd35aa64f6267b87262d0
https://doi.org/10.1111/dom.15006
https://doi.org/10.1111/dom.15006
Autor:
Fumika Shigiyama, Shinji Hisatake, Takanori Ikeda, Takahisa Hirose, Shigenori Hiruma, Nobuyuki Shiraga, Naoki Kumashiro
Publikováno v:
Diabetes Therapy
Introduction Ectopic fat accumulation has been found to play a pathophysiological role in insulin resistance, type 2 diabetes (T2DM), and coronary artery diseases. Findings from a number of previous studies suggest that sodium glucose cotransporter 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137b757ec2fb4c773a9265e759c196f3
https://doi.org/10.1007/s13300-019-0640-4
https://doi.org/10.1007/s13300-019-0640-4
Autor:
Takahisa Hirose, Shigenori Hiruma, Nobuyuki Shiraga, Naoki Kumashiro, Masaaki Hori, Takanori Ikeda, Shinji Hisatake, Fumika Shigiyama, Sunao Mizumura
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Background While the cardioprotective benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors have been established in patients with cardiovascular disease (CVD), their advantages over other anti-diabetic drugs at earlier stages remain unclear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d9a02a91b646466674ae5710c6b01d
https://doi.org/10.1186/s12933-021-01228-3
https://doi.org/10.1186/s12933-021-01228-3